Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Arrhythmias

  Free Subscription


Articles published in Stroke

Retrieve available abstracts of 77 articles:
HTML format
Text format



Single Articles


    April 2017
  1. LUBITZ SA, Seshadri S, Benjamin EJ
    Response by Lubitz et al to Letter Regarding Article, "Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study".
    Stroke. 2017 Apr 17. pii: STROKEAHA.117.017108.
    PubMed     Text format    


  2. SPOSATO LA, Fridman S, Saposnik G
    Letter by Sposato et al Regarding Article, "Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study".
    Stroke. 2017 Apr 17. pii: STROKEAHA.117.017066.
    PubMed     Text format    


  3. COLL-VINENT B, Martin A, Sanchez J, Tamargo J, et al
    Benefits of Emergency Departments' Contribution to Stroke Prophylaxis in Atrial Fibrillation: The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation).
    Stroke. 2017 Apr 7. pii: STROKEAHA.116.014855. doi: 10.1161/STROKEAHA.116.014855
    PubMed     Text format     Abstract available


    March 2017
  4. NIELSEN PB, Johnsen SP
    Letter by Nielsen and Johnsen Regarding Article, "Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial Fibrillation".
    Stroke. 2017 Mar 10. pii: STROKEAHA.117.016747.
    PubMed     Text format    


  5. PENNLERT J, Asplund K, Eriksson M
    Response by Pennlert et al to Letter Regarding Article, "Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial Fibrillation".
    Stroke. 2017 Mar 10. pii: STROKEAHA.117.016838.
    PubMed     Text format    


  6. PROIETTI M, Guiducci E, Cheli P, Lip GY, et al
    Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials.
    Stroke. 2017 Mar 6. pii: STROKEAHA.116.015984. doi: 10.1161/STROKEAHA.116.015984
    PubMed     Text format     Abstract available


  7. SCHWAMMENTHAL Y, Tsabari R, Orion D, Merzlyak O, et al
    Shifting Perceptions of Risk and Reward: Use of Anticoagulation in Patients With Acute Brain Ischemia and Atrial Fibrillation: Nine-Year Data From a National Acute Stroke Registry (National Acute Stroke Israeli Survey [NASIS]).
    Stroke. 2017 Mar 3. pii: STROKEAHA.116.015776. doi: 10.1161/STROKEAHA.116.015776
    PubMed     Text format     Abstract available


    February 2017
  8. BAI Y, Deng H, Shantsila A, Lip GY, et al
    Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis.
    Stroke. 2017 Feb 17. pii: STROKEAHA.116.016275.
    PubMed     Text format     Abstract available


  9. PACIARONI M, Agnelli G, Caso V, Tsivgoulis G, et al
    Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients With Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study.
    Stroke. 2017 Feb 9. pii: STROKEAHA.116.015770. doi: 10.1161/STROKEAHA.116.015770
    PubMed     Text format     Abstract available


  10. LANG C, Seyfang L, Ferrari J, Gattringer T, et al
    Do Women With Atrial Fibrillation Experience More Severe Strokes? Results From the Austrian Stroke Unit Registry.
    Stroke. 2017 Feb 1. pii: STROKEAHA.116.015900. doi: 10.1161/STROKEAHA.116.015900
    PubMed     Text format     Abstract available


    January 2017
  11. LUBITZ SA, Yin X, McManus DD, Weng LC, et al
    Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study.
    Stroke. 2017 Jan 12. pii: STROKEAHA.116.015071.
    PubMed     Text format     Abstract available


    December 2016
  12. PENNLERT J, Overholser R, Asplund K, Carlberg B, et al
    Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial Fibrillation.
    Stroke. 2016 Dec 20. pii: STROKEAHA.116.014643.
    PubMed     Text format     Abstract available


  13. HERNANDEZ I, Zhang Y, Brooks MM, Chin PK, et al
    Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation.
    Stroke. 2016 Dec 1. pii: STROKEAHA.116.015150.
    PubMed     Text format     Abstract available


    October 2016
  14. ACAMPA M, Lazzerini PE, Martini G
    Letter by Acampa et al Regarding Article, "Underutilization of Ambulatory ECG Monitoring After Stroke and Transient Ischemic Attack: Missed Opportunities for Atrial Fibrillation Detection".
    Stroke. 2016 Oct 18. pii: STROKEAHA.116.014947.
    PubMed     Text format    


  15. BONDE AN, Lip GY, Kamper AL, Fosbol EL, et al
    Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation: An Observational Cohort Study.
    Stroke. 2016 Oct 6. pii: STROKEAHA.116.014422.
    PubMed     Text format     Abstract available


    September 2016
  16. CHAO TF, Lip GY, Liu CJ, Tuan TC, et al
    Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study.
    Stroke. 2016 Sep 13. pii: STROKEAHA.116.013880.
    PubMed     Text format     Abstract available


    August 2016
  17. BUCHWALD F, Norrving B, Petersson J
    Atrial Fibrillation in Transient Ischemic Attack Versus Ischemic Stroke: A Swedish Stroke Register (Riksstroke) Study.
    Stroke. 2016 Aug 25. pii: STROKEAHA.116.013988.
    PubMed     Text format     Abstract available


  18. KOGA M, Yoshimura S, Hasegawa Y, Shibuya S, et al
    Higher Risk of Ischemic Events in Secondary Prevention for Patients With Persistent Than Those With Paroxysmal Atrial Fibrillation.
    Stroke. 2016 Aug 16. pii: STROKEAHA.116.013746.
    PubMed     Text format     Abstract available


  19. FAUCHIER L, Bisson A, Lip GY
    Response by Fauchier et al to Letter Regarding Article, "Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?"
    Stroke. 2016 Aug 11. pii: STROKEAHA.116.014619.
    PubMed     Text format    


  20. ZHANG H, Hao YG, Xu G
    Letter by Zhang et al Regarding Article, "Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?"
    Stroke. 2016 Aug 11. pii: STROKEAHA.116.014301.
    PubMed     Text format    


  21. PERERA KS, Vanassche T, Bosch J, Swaminathan B, et al
    Global Survey of the Frequency of Atrial Fibrillation-Associated Stroke: Embolic Stroke of Undetermined Source Global Registry.
    Stroke. 2016 Aug 9. pii: STROKEAHA.116.013378.
    PubMed     Text format     Abstract available


    July 2016
  22. EDWARDS JD, Kapral MK, Fang J, Saposnik G, et al
    Underutilization of Ambulatory ECG Monitoring After Stroke and Transient Ischemic Attack: Missed Opportunities for Atrial Fibrillation Detection.
    Stroke. 2016 Jul 12. pii: STROKEAHA.115.012195.
    PubMed     Text format     Abstract available


  23. ROST NS, Giugliano RP, Ruff CT, Murphy SA, et al
    Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48.
    Stroke. 2016 Jul 7. pii: STROKEAHA.116.013540.
    PubMed     Text format     Abstract available


    June 2016
  24. NIELSEN PB, Larsen TB, Lip GY
    Letter by Nielsen et al Regarding Article, "Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis".
    Stroke. 2016 Jun 9. pii: STROKEAHA.116.013672.
    PubMed     Text format    


  25. CHANG SS, Dong JZ, Ma CS, Du X, et al
    Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation: The Chinese Atrial Fibrillation Registry Study.
    Stroke. 2016 Jun 9. pii: STROKEAHA.116.012988.
    PubMed     Text format     Abstract available


  26. JOUNDI RA, Cipriano LE, Sposato LA, Saposnik G, et al
    Response to Letter Regarding Article, "Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis".
    Stroke. 2016 Jun 9. pii: STROKEAHA.116.013721.
    PubMed     Text format    


  27. STOKER TB, Evans NR
    Managing Risk After Intracerebral Hemorrhage in Concomitant Atrial Fibrillation and Cerebral Amyloid Angiopathy.
    Stroke. 2016 Jun 7. pii: STROKEAHA.116.013323.
    PubMed     Text format    


  28. BEKWELEM W, Jensen PN, Norby FL, Soliman EZ, et al
    Carotid Atherosclerosis and Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities Study.
    Stroke. 2016;47:1643-6.
    PubMed     Text format     Abstract available


  29. HENNINGER N, Goddeau RP Jr, Karmarkar A, Helenius J, et al
    Atrial Fibrillation Is Associated With a Worse 90-Day Outcome Than Other Cardioembolic Stroke Subtypes.
    Stroke. 2016;47:1486-92.
    PubMed     Text format     Abstract available


    May 2016
  30. FAUCHIER L, Clementy N, Bisson A, Ivanes F, et al
    Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?
    Stroke. 2016 May 26. pii: STROKEAHA.116.013253.
    PubMed     Text format     Abstract available


  31. YOO J, Song D, Baek JH, Kim YD, et al
    Poor Outcome of Stroke Patients With Atrial Fibrillation in the Presence of Coexisting Spontaneous Echo Contrast.
    Stroke. 2016 May 17. pii: STROKEAHA.116.013351.
    PubMed     Text format     Abstract available


  32. WERRING DJ, Wilson D, Marti-Fabregas J
    Letter by Werring et al Regarding Article, "Embolic Stroke, Atrial Fibrillation, and Microbleeds: Is There a Role for Anticoagulation?"
    Stroke. 2016 May 3. pii: STROKEAHA.116.013530.
    PubMed     Text format    


    April 2016
  33. SENOO K, Lip GY
    Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin.
    Stroke. 2016 Apr 28. pii: STROKEAHA.116.013173.
    PubMed     Text format     Abstract available


  34. SHAH A, Shewale A, Hayes CJ, Martin BC, et al
    Cost Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients.
    Stroke. 2016 Apr 21. pii: STROKEAHA.115.012325.
    PubMed     Text format     Abstract available


    March 2016
  35. JOUNDI RA, Cipriano LE, Sposato LA, Saposnik G, et al
    Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis.
    Stroke. 2016 Mar 29. pii: STROKEAHA.115.012609.
    PubMed     Text format     Abstract available


  36. RIZOS T, Veltkamp R
    Response to Letter Regarding Article, "Preexisting Heart Disease Underlies Newly Diagnosed Atrial Fibrillation After Acute Ischemic Stroke".
    Stroke. 2016 Mar 24. pii: STROKEAHA.116.013108.
    PubMed     Text format    


  37. DOGANAY F, Katlandur H, Ozdil H
    Letter by Doganay et al Regarding Article, "Preexisting Heart Disease Underlies Newly Diagnosed Atrial Fibrillation After Acute Ischemic Stroke".
    Stroke. 2016 Mar 24. pii: STROKEAHA.116.013058.
    PubMed     Text format    


  38. HARUKI S, Minami Y, Hagiwara N
    Stroke and Embolic Events in Hypertrophic Cardiomyopathy: Risk Stratification in Patients Without Atrial Fibrillation.
    Stroke. 2016 Mar 3. pii: STROKEAHA.115.012130.
    PubMed     Text format     Abstract available


  39. DIENER HC, Selim MH, Molina CA, Greenberg SM, et al
    Embolic Stroke, Atrial Fibrillation, and Microbleeds: Is There a Role for Anticoagulation?
    Stroke. 2016;47:904-7.
    PubMed     Text format    


    February 2016
  40. VESTERGAARD AS, Skjoth F, Lip GY, Larsen TB, et al
    Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation: A Registry Study.
    Stroke. 2016 Feb 16. pii: STROKEAHA.115.012338.
    PubMed     Text format     Abstract available


    January 2016
  41. ALLENDE M, Molina E, Gonzalez-Porras JR, Toledo E, et al
    Short Leukocyte Telomere Length Is Associated With Cardioembolic Stroke Risk in Patients With Atrial Fibrillation.
    Stroke. 2016 Jan 19. pii: STROKEAHA.115.011837.
    PubMed     Text format     Abstract available


  42. KAMEL H, Okin PM, Elkind MS, Iadecola C, et al
    Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model.
    Stroke. 2016 Jan 19. pii: STROKEAHA.115.012004.
    PubMed     Text format    


  43. RIZOS T, Horstmann S, Dittgen F, Tager T, et al
    Preexisting Heart Disease Underlies Newly Diagnosed Atrial Fibrillation After Acute Ischemic Stroke.
    Stroke. 2016 Jan 7. pii: STROKEAHA.115.011465.
    PubMed     Text format     Abstract available


  44. PASSMAN R, Bernstein RA
    New Appraisal of Atrial Fibrillation Burden and Stroke Prevention.
    Stroke. 2016 Jan 5. pii: STROKEAHA.115.009930.
    PubMed     Text format    


  45. CHAN YH, Yen KC, See LC, Chang SH, et al
    Cardiovascular, Bleeding, and Mortality Risks of Dabigatran in Asians With Nonvalvular Atrial Fibrillation.
    Stroke. 2016 Jan 5. pii: STROKEAHA.115.011476.
    PubMed     Text format     Abstract available


    December 2015
  46. YANG X, Li Z, Zhao X, Wang C, et al
    Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China.
    Stroke. 2015 Dec 22. pii: STROKEAHA.115.011833.
    PubMed     Text format     Abstract available


  47. SENOO K, Lip GY
    Body Mass Index and Adverse Outcomes in Elderly Patients With Atrial Fibrillation: The AMADEUS Trial.
    Stroke. 2015 Dec 1. pii: STROKEAHA.115.011876.
    PubMed     Text format     Abstract available


    November 2015
  48. NADKARNI GN, Patel AA, Konstantinidis I, Mahajan A, et al
    Dialysis Requiring Acute Kidney Injury in Acute Cerebrovascular Accident Hospitalizations.
    Stroke. 2015;46:3226-31.
    PubMed     Text format     Abstract available


    October 2015
  49. TAKABAYASHI K, Hamatani Y, Yamashita Y, Takagi D, et al
    Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation: The Fushimi Atrial Fibrillation Registry.
    Stroke. 2015 Oct 29. pii: STROKEAHA.115.010947.
    PubMed     Text format     Abstract available


  50. YAGHI S, Song C, Gray WA, Furie KL, et al
    Left Atrial Appendage Function and Stroke Risk.
    Stroke. 2015 Oct 27. pii: STROKEAHA.115.011273.
    PubMed     Text format    


  51. HAYDEN DT, Hannon N, Callaly E, Nii Chroiiniin D, et al
    Rates and Determinants of 5-Year Outcomes After Atrial Fibrillation-Related Stroke: A Population Study.
    Stroke. 2015 Oct 15. pii: STROKEAHA.115.011139.
    PubMed     Text format     Abstract available


  52. SENOO K, Lip GY
    Relationship of Age With Stroke and Death in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: AMADEUS Trial.
    Stroke. 2015 Oct 13. pii: STROKEAHA.115.010614.
    PubMed     Text format     Abstract available


    September 2015
  53. POGGESI A, Inzitari D, Pantoni L
    Atrial Fibrillation and Cognition: Epidemiological Data and Possible Mechanisms.
    Stroke. 2015 Sep 22. pii: STROKEAHA.115.008225.
    PubMed     Text format    


  54. KAMEL H, Hunter M, Moon YP, Yaghi S, et al
    Electrocardiographic Left Atrial Abnormality and Risk of Stroke: Northern Manhattan Study.
    Stroke. 2015 Sep 22. pii: STROKEAHA.115.009989.
    PubMed     Text format     Abstract available


  55. SCRUTINIO D, Monitillo V, Guida P, Nardulli R, et al
    Functional Gain After Inpatient Stroke Rehabilitation: Correlates and Impact on Long-Term Survival.
    Stroke. 2015 Sep 3. pii: STROKEAHA.115.010440.
    PubMed     Text format     Abstract available


  56. KATE M, Gioia L, Buck B, Sivakumar L, et al
    Dabigatran Therapy in Acute Ischemic Stroke Patients Without Atrial Fibrillation.
    Stroke. 2015;46:2685-7.
    PubMed     Text format     Abstract available


  57. WANG KL, Lip GY, Lin SJ, Chiang CE, et al
    Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-Analysis.
    Stroke. 2015;46:2555-61.
    PubMed     Text format     Abstract available


    August 2015
  58. LIP GY, Lanitis T, Mardekian J, Kongnakorn T, et al
    Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients.
    Stroke. 2015 Aug 27. pii: STROKEAHA.115.009995.
    PubMed     Text format     Abstract available


  59. NORRVING B, Bray BD, Asplund K, Heuschmann P, et al
    Cross-National Key Performance Measures of the Quality of Acute Stroke Care in Western Europe.
    Stroke. 2015 Aug 11. pii: STROKEAHA.115.008811.
    PubMed     Text format     Abstract available


  60. FAUCHIER L, Clementy N, Pelade C, Collignon C, et al
    Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study.
    Stroke. 2015 Aug 6. pii: STROKEAHA.115.010270.
    PubMed     Text format     Abstract available


  61. SILVER B, Windecker S
    Response to Letter Regarding Article, "Prognostications of Fibrillations".
    Stroke. 2015;46:e191.
    PubMed     Text format    


  62. SANNA T
    Letter by Sanna Regarding Article, "Prognostications of Fibrillations".
    Stroke. 2015;46:e190.
    PubMed     Text format    


    July 2015
  63. SENOO K, Lip GY, Lane DA, Buller HR, et al
    Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial.
    Stroke. 2015 Jul 23. pii: STROKEAHA.115.009487.
    PubMed     Text format     Abstract available


  64. PENNLERT J, Asplund K, Carlberg B, Wiklund PG, et al
    Antithrombotic Treatment Following Intracerebral Hemorrhage in Patients With and Without Atrial Fibrillation.
    Stroke. 2015 Jul 9. pii: STROKEAHA.115.009087.
    PubMed     Text format     Abstract available


  65. OVERVAD TF, Skjoth F, Lip GY, Lane DA, et al
    Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation: Nationwide Cohort Study.
    Stroke. 2015 Jul 7. pii: STROKEAHA.115.009371.
    PubMed     Text format     Abstract available


  66. BERGUI M, Castagno D, D'Agata F, Cicerale A, et al
    Selective Vulnerability of Cortical Border Zone to Microembolic Infarct.
    Stroke. 2015;46:1864-9.
    PubMed     Text format     Abstract available


    June 2015
  67. PACIARONI M, Agnelli G, Falocci N, Caso V, et al
    Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study.
    Stroke. 2015 Jun 30. pii: STROKEAHA.115.008891.
    PubMed     Text format     Abstract available


  68. SJOLANDER M, Eriksson M, Asplund K, Norrving B, et al
    Socioeconomic Inequalities in the Prescription of Oral Anticoagulants in Stroke Patients With Atrial Fibrillation.
    Stroke. 2015 Jun 16. pii: STROKEAHA.115.009718.
    PubMed     Text format     Abstract available


    May 2015
  69. SILVER B, Windecker S
    Prognostications of fibrillations.
    Stroke. 2015;46:1155-7.
    PubMed     Text format    


    April 2015
  70. YAGHI S, Moon YP, Mora-McLaughlin C, Willey JZ, et al
    Left Atrial Enlargement and Stroke Recurrence: The Northern Manhattan Stroke Study.
    Stroke. 2015 Apr 23. pii: STROKEAHA.115.008711.
    PubMed     Text format     Abstract available


  71. AGARWAL SK, Chao J, Peace F, Judd SE, et al
    Premature Ventricular Complexes on Screening Electrocardiogram and Risk of Ischemic Stroke.
    Stroke. 2015 Apr 14. pii: STROKEAHA.114.008447.
    PubMed     Text format     Abstract available


    February 2015
  72. KAMEL H, Bartz TM, Longstreth WT Jr, Okin PM, et al
    Association Between Left Atrial Abnormality on ECG and Vascular Brain Injury on MRI in the Cardiovascular Health Study.
    Stroke. 2015 Feb 12. pii: STROKEAHA.114.007762.
    PubMed     Text format     Abstract available


  73. CHAN PH, Hai JJ, Siu CW
    Response to Letter Regarding Article, "Ischemic Stroke and Intracranial Hemorrhage With Aspirin, Dabigatran, and Warfarin: Impact of Quality of Anticoagulation Control"
    Stroke. 2015 Feb 3. pii: STROKEAHA.114.008581.
    PubMed     Text format    


  74. FENG X, Huan Y, Lv Y
    Letter by Feng et al Regarding Article, "Ischemic Stroke and Intracranial Hemorrhage With Aspirin, Dabigatran, and Warfarin: Impact of Quality of Anticoagulation Control"
    Stroke. 2015 Feb 3. pii: STROKEAHA.114.008578.
    PubMed     Text format    


    January 2015
  75. MAHAGNE MH, Lachaud S, Suissa L
    Letter by Mahagne et al Regarding Article, "Embolic Strokes of Undetermined Source in the Athens Stroke Registry: A Descriptive Analysis"
    Stroke. 2015 Jan 27. pii: STROKEAHA.114.008546.
    PubMed     Text format    


  76. NTAIOS G, Vemmos K
    Response to Letter Regarding Article, "Embolic Stroke of Undetermined Source in the Athens Stroke Registry: A Descriptive Analysis"
    Stroke. 2015 Jan 27. pii: STROKEAHA.114.008577.
    PubMed     Text format    


    December 2014
  77. KURKA N, Bobinger T, Kallmunzer B, Koehn J, et al
    Reliability and Limitations of Automated Arrhythmia Detection in Telemetric Monitoring After Stroke.
    Stroke. 2014 Dec 23. pii: STROKEAHA.114.007892.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: